Literature DB >> 7966631

Substitutions in the capsids of poliovirus mutants selected in human neuroblastoma cells confer on the Mahoney type 1 strain a phenotype neurovirulent in mice.

T Couderc1, N Guédo, V Calvez, I Pelletier, J Hogle, F Colbère-Garapin, B Blondel.   

Abstract

Poliovirus (PV) type 1 mutants selected in human neuroblastoma cells persistently infected (PVpi) with the wild-type Mahoney strain exhibited a mouse-neurovirulent phenotype. Four of the five substitutions present in the capsid proteins of a PVpi were demonstrated to extend the host range of the Mahoney strain to mice. These new mouse-neurovirulent determinants were located in the three-dimensional structure of the viral capsid; two of them (residues 142 of VP2 and 60 of VP3) were located in loops exposed at the surface of the protein shell, whereas the other two (residues 43 of VP1 and 62 of VP4) were located on the inside of the capsid. VP1 residue 43 and VP2 residue 142 substitutions were also selected in a PVpi derived from the attenuated Sabin strain. We suggest that the selective pressure of human neuroblastoma cell factor(s) involved in early steps of PV multiplication could be responsible for the arising of amino acid substitutions which confer adaptation to the mouse central nervous system to PV.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7966631      PMCID: PMC237308          DOI: 10.1128/JVI.68.12.8386-8391.1994

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  An improved method for sequencing of RNA templates.

Authors:  O Fichot; M Girard
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

2.  Characterization of persistent poliovirus mutants selected in human neuroblastoma cells.

Authors:  I Pelletier; T Couderc; S Borzakian; E Wyckoff; R Crainic; E Ehrenfeld; F Colbere-Garapin
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

3.  A monoclonal antibody that blocks poliovirus attachment recognizes the lymphocyte homing receptor CD44.

Authors:  M P Shepley; V R Racaniello
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

4.  Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding.

Authors:  C E Fricks; J M Hogle
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

5.  Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis.

Authors:  R B Ren; F Costantini; E J Gorgacz; J J Lee; V R Racaniello
Journal:  Cell       Date:  1990-10-19       Impact factor: 41.582

6.  Persistent poliovirus infection of human neuroblastoma cells.

Authors:  F Colbère-Garapin; C Christodoulou; R Crainic; I Pelletier
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

7.  Transgenic mice susceptible to poliovirus.

Authors:  S Koike; C Taya; T Kurata; S Abe; I Ise; H Yonekawa; A Nomoto
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

8.  The poliovirus receptor protein is produced both as membrane-bound and secreted forms.

Authors:  S Koike; H Horie; I Ise; A Okitsu; M Yoshida; N Iizuka; K Takeuchi; T Takegami; A Nomoto
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

9.  Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus.

Authors:  D J Filman; R Syed; M Chow; A J Macadam; P D Minor; J M Hogle
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

10.  Host range determinants located on the interior of the poliovirus capsid.

Authors:  E G Moss; V R Racaniello
Journal:  EMBO J       Date:  1991-05       Impact factor: 11.598

View more
  18 in total

Review 1.  Poliovirus cell entry: common structural themes in viral cell entry pathways.

Authors:  James M Hogle
Journal:  Annu Rev Microbiol       Date:  2002-01-30       Impact factor: 15.500

2.  Allele-specific adaptation of poliovirus VP1 B-C loop variants to mutant cell receptors.

Authors:  S Liao; V Racaniello
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

3.  Broad and Dynamic Diversification of Infectious Hepatitis C Virus in a Cell Culture Environment.

Authors:  Isabel Gallego; María Eugenia Soria; Carlos García-Crespo; Qian Chen; Patricia Martínez-Barragán; Soumaya Khalfaoui; Brenda Martínez-González; Irene Sanchez-Martin; Inés Palacios-Blanco; Ana Isabel de Ávila; Damir García-Cehic; Juan Ignacio Esteban; Jordi Gómez; Carlos Briones; Josep Gregori; Josep Quer; Celia Perales; Esteban Domingo
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

4.  Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5' nontranslated region.

Authors:  J J Dunn; N M Chapman; S Tracy; J R Romero
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

5.  Molecular genetic analysis of revertants from a poliovirus mutant that is specifically adapted to the mouse spinal cord.

Authors:  Q Jia; J M Hogle; T Hashikawa; A Nomoto
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine.

Authors:  M J Bouchard; D H Lam; V R Racaniello
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

7.  A point mutation in the VP4 coding sequence of coxsackievirus B4 influences virulence.

Authors:  A I Ramsingh; D N Collins
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Persistent infection promotes cross-species transmissibility of mouse hepatitis virus.

Authors:  R S Baric; E Sullivan; L Hensley; B Yount; W Chen
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  Persistent equine arteritis virus infection in HeLa cells.

Authors:  Jianqiang Zhang; Peter J Timoney; N James MacLachlan; William H McCollum; Udeni B R Balasuriya
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

10.  Mouse adaptation determinants of poliovirus type 1 enhance viral uncoating.

Authors:  T Couderc; F Delpeyroux; H Le Blay; B Blondel
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.